baber/WOPTO huggingface dataset:
Patent AU-2012244081-B2 (AU)
Title: Apparatus and methods for network identification of open market wireless devices
Inventor: QU HAI
IPC: H04W8/24
Filed: 2012-10-19
Granted: 2014-09-25
Abstract: Methods, apparatus and systems are presented for automatically providing network operators with identification of open market wireless devices that are used in the operator s respective network. Present aspects accomplish such by retrieving device profile information in response to the network operator s removable module being associated with (i.e., inserted into) a wireless device and communicating the device profile information to the network operator or the like. This allows for the network operator or third party entity to track and/or monitor the type of wireless devices existing in their respective wireless network. In addition, the automated nature of the tracking obviates the need for the subscribers/users of the removable modules to manually or otherwise provide the device identification to the network operators. Receive a Removable Module at a Wireless Communication Device, the 300 Removable Module including Configuration to Enable Communication with a Wireless Network 302 |Launch an Removable Module-Based Device Identification Application Determine that Network Identification 304 of the Wireless Communication Device is Necessary Retrieve Device Profile Information 306 from Wireless Device Memory, in Response to the Receipt of the Removable Module Generate a Device Identification Message that 308 Includes at Least a Portion of the Device Profile Information Communicate the Device Identification Message, 310 via the Wireless Network, to a Network Operator Associated with the Removable Module --------------------- I------------ 312 Store the Device Identifier in Removable Module Memory ---------------------------------------------
Patent AU-2012249421-B2 (AU)
Title: 17alpha-hydroxylase/C17,20-lyase inhibitors
Inventor: BOCK MARK GARY
IPC: A61K31/4436
Filed: 2012-04-27
Granted: 2015-09-24
Abstract: The present invention provides compounds of Formula (I), or a pharmaceutically acceptable salt thereof, where R
Patent AU-2012258350-B2 (AU)
Title: Controlled release formulations
Inventor: ANDERSEN CHRISTINE
IPC: A61K9/20
Filed: 2012-11-22
Granted: 2014-10-23
Abstract: The present invention relates to the field of controlled release formulations, and in particular to formulations useful for once daily administration. More particular, the present invention relates to compositions, which are formulated for continued administration to an individual in need thereof within the range of 20 to 28 hours interval between individual administrations
Patent AU-2012267578-B2 (AU)
Title: Cleavable lipids
Inventor: HEARTLEIN MICHAEL
IPC: A61K31/4164
Filed: 2012-06-08
Granted: 2017-04-20
Abstract: Disclosed herein are novel compounds, pharmaceutical compositions comprising such compounds and related methods of their use. The compounds described herein are useful, e.g., as liposomal delivery vehicles to facilitate the delivery of encapsulated polynucleotides to target cells and subsequent iransfection of said target cells, and in certain embodiments are characterized as having one or more properties that afford such compounds advantages relative to other similarly classified lipids.
Patent AU-2012273436-B2 (AU)
Title: Static dissipative fluid conveying coupler
Inventor: COHEN DAVID
IPC: B29C70/88
Filed: 2012-05-10
Granted: 2016-12-15
Abstract: A rigid coupler (300) for use in electrically isolating an electrically conductive fluid conveyance system is described. The rigid coupler (300) includes a nonconductive liner (306) having a first end configured to couple to a first adjoining section of the fluid conveyance system, and a second end, opposite said first end, configured to couple to a second adjoining section of the fluid conveyance system. A reinforcing structure (308) circumscribes the nonconductive liner (306) and is coupled to a portion of the nonconductive liner (306) extending between the first and second ends of the nonconductive liner. The reinforcing structure (308) includes a multi-axial braided fiber material impregnated with a matrix material. A fiber overwrap (310) is hoop wound about at a least a portion of the reinforcing structure (308) between the first and second ends of the nonconductive liner (306).
Patent AU-2012277566-B2 (AU)
Title: Personal health data collection
Inventor: ELLIOTT CHRISTOPHER
IPC: A61B5/021
Filed: 2012-06-26
Granted: 2016-04-28
Abstract: The present application relates to means for collecting personal health data, in particular to a personal hand-held monitor (hereafter "a PHHM") comprising a signal acquisition device for acquiring signals which can be used to derive one or more measurements of parameters related to the health of a user, the signal acquisition device being integrated with a personal hand-held computing device (hereafter "a PHHCD"). The PHHM uses the processor of the PHHCD to control and analyse signals received from the signal acquisition device. The present application also relates to a signal acquisition device adapted to be integrated with such a PHHCD and to systems for operating the PHHM and for handling the signals acquired by the signal acquisition device. The present application further relates to a system for analysing, storing and transmitting signals acquired by the PHHM via the Internet or for regulating the uses to which the data derived from those signals may be put. A PHHM comprises a signal acquisition device (4) for acquiring signals which can be used to derive a measurement of a parameter related to the health of the user, the signal acquisition device being integrated with the PHHCD, wherein the parameter is blood pressure and the signal acquisition device comprises a blood flow occlusion means (21) adapted to be pressed against one side only of a body part or to have one side only of a body part pressed against it, a means (4) for measuring the pressure applied by or to the body part, and a means for detecting the flow of blood through the body part in contact with the blood flow occlusion means.
Patent AU-2012307104-B2 (AU)
Title: Inhaler
Inventor: BERRY SIMON CHRISTOPHER
IPC: A61M15/00
Filed: 2012-09-12
Granted: 2017-03-02
Abstract: An inhaler for delivery of a medicament by inhalation is disclosed. The inhaler comprises a dispensing mechanism, the dispensing mechanism being configured to dispense a dose of medicament on actuation. The inhaler further comprises a dose counting mechanism comprising a counter and a translating member. The translating member comprises a pawl. The counter comprises a first count wheel, a second count wheel and an intermediate wheel engaged with the second count wheel and in selective engagement with the first count wheel. When the inhaler is fired to dispense a dose of medicament, the dispensing mechanism moves the translating member in a substantially linear direction. The pawl thus rotates the first count wheel, and as the first count wheel rotates, the intermediate wheel is selectively engaged thereby selectively rotating the second count wheel to count the doses of the inhaler.
Patent AU-2012321723-B2 (AU)
Title: Tablet comprising 7- [ 4- (4-benzo[ b] thiophen-4-yl-piperazin-1-yl)butoxy] - 1H-quinolin-2-one or a salt thereof
Inventor: INOUE YOSHIHARU
IPC: A61K47/38
Filed: 2012-10-12
Granted: 2017-07-20
Abstract: Provided is a tablet containing the active ingredient of 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl) butoxy]-1H-quinolin-2-one or a salt thereof, the tablet having excellent disintegration, favorable storage stability, and high light stability; in particular, provided is a tablet obtained by coating, with a coating layer containing hypromellose, talc, titanium oxide, and a colorant or the like, a plain tablet which contains 7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl) butoxy]-1H-quinolin-2-one or a salt thereof as an active ingredient, and also contains: lactose, corn starch, crystalline cellulose, or another excipient; low-substituted hydroxypropyl cellulose, croscarmellose sodium, sodium carboxymethyl starch, or another disintegrating agent; hydroxypropyl cellulose or another binder; and stearic acid salt or another lubricant.
Patent AU-2012351805-B2 (AU)
Title: Samidorphan (ALKS 33) in combination with opioid agonists
Inventor: DEAVER DANIEL
IPC: A61K45/06
Filed: 2012-12-17
Granted: 2016-04-21
Abstract: The invention relates a composition comprising an opioid agonist and Compound- 1 : Compound- 1.
Patent AU-2012380672-B2 (AU)
Title: Process for preparing crystalline Sorafenib tosylate
Inventor: PUROHIT PRASHANT
IPC: A61K31/44
Filed: 2012-12-31
Granted: 2015-05-14
Abstract: The present invention provides an industrially suitable process for the preparation of substantially pure 4-{4-[({[4-chloro-3-(trifluoromethyl)-phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide or Sorafenib and its tosylate salt, with a suitable impurity profile and without requirement of any additional purification steps. The present invention also provides Sorafenib base (II) as stable crystalline Form-SSB. The present invention further relates to a process for the preparation of crystalline Sorafenib tosylate Form-I which is free from contamination of any other polymorphic form of Sorafenib tosylate, for e.g. Form II or Form III, and does not involve any seeding requirement for crystallization step.
Patent AU-2012386508-B2 (AU)
Title: Remote activated deflector
Inventor: DONOVAN STACEY BLAINE
IPC: E21B34/16
Filed: 2012-08-01
Granted: 2016-01-07
Abstract: A wellbore y-block junction comprises a first bore channel, a second bore channel, a deflector selectable to a neutral position, to a first bore channel selected position, and to a second bore channel selected position, a radio receiver, and a controller, wherein the controller is configured to command the deflector position to one of the neutral position, the first bore channel selected position, or the second bore channel selected position based on an input from the radio receiver.
Patent AU-2013202764-B2 (AU)
Title: Improvements in and relating to pumps
Inventor: BURGESS KEVIN EDWARD
IPC: F04D29/44
Filed: 2013-04-06
Granted: 2016-01-07
Abstract: IMPROVEMENTS IN AND RELATING TO PUMPS Abstract A pump assembly and components therefor including an impeller which has flow inducer elements on an inner surface of a front shroud thereof, a flow directing device or strainer having passageways for delivering material to the impeller and at least one flow circulating passageway and a pump casing having an intake section with flow distribution vanes in the region of a feed opening adjacent the intake section.
Patent AU-2013202912-B2 (AU)
Title: Modulation of chemosensory receptors and ligands associated therewith
Inventor: TACHDJIAN CATHERINE
IPC: A61K31/519
Filed: 2013-04-08
Granted: 2016-10-27
Abstract: The present invention includes methods for identifying modifiers of chemosensory receptors and their ligands, e.g., by determining whether a test entity is suitable to interact with one or more interacting sites within the Venus flytrap domains of the chemosensory receptors, and modifiers 5 capable of modulating chemosensory receptors and their ligands. The present invention also includes modifiers of chemosensory receptors and their ligands having Formula (1), its subgenus, and specific compounds. Furthermore, the present invention includes ingestible compositions comprising the modifiers of chemosensory receptors and their ligands and methods of using the modifiers of chemosensory receptors and their ligands to enhance the 0 sweet taste of an ingestible composition or treat a condition associated with a chemosensory receptor. In addition, the present invention include processes for preparing the modifiers of chemosensory receptors and their ligands.
Patent AU-2013205623-B2 (AU)
Title: Fluid Flow Indicator
Inventor: LOGAN KENNETH ARTHUR
IPC: A61M5/14
Filed: 2013-05-02
Granted: 2015-02-12
Abstract: A fluid flow indicator for observation of low flow rates in liquids includes a capillary tube (12) slidably mounted at each end in passageways (4) and (5) and biased into a no- flow indicating position by a castellated elastomeric membrane (14) providing a sealed barrier within a chamber (1) between a first zone (17) and a second zone (18). Fluid flow introduced through spigot (9) causes the capillary tube (12) to slide to the opposite end of the passageways (4) and (5) whereupon the deformed position of the elastomeric membrane (14) can readily be observed through transparent walls (3) in the chamber (1). Upon cessation of flow, the elastomeric membrane (14) causes the capillary tube (12) to revert to its original position. WO 2007/098565 PCT/AU2007/000266 -7
Patent AU-2013216632-B2 (AU)
Title: Intravenous antiviral treatments
Inventor: KILPATRICK JOHN MICHAEL
IPC: A61K31/196
Filed: 2013-08-14
Granted: 2016-09-01
Abstract: The invention provides unit dosage forms, kits and methods useful for treating viral infections.
Patent AU-2013218765-B2 (AU)
Title: Retractable latch bumper
Inventor: GRUBER RUDOLF
IPC: B60J5/10
Filed: 2013-02-07
Granted: 2017-02-02
Abstract: A bumper for a closure, such as a tailgate, acts between the tailgate and a frame to bias a striker in to engagement with a latch. The bumper is moved to a retracted position during closing to reduce the force needed to close the tailgate. After latching, the bumper is conditioned to an extended position to assert the bias between the tailgate and frame.
Patent AU-2013219442-B2 (AU)
Title: Aqueous pigment dispersion liquid and aqueous pigment inkjet ink using same
Inventor: SHIMANAKA HIROYUKI
IPC: C09B67/20
Filed: 2013-02-08
Granted: 2015-09-03
Abstract: An aqueous pigment dispersion liquid for inkjet, which contains a pigment and a pigment dispersant. The pigment dispersant is composed of a graft copolymer and/or a block copolymer, each of which contains a polymer chain (A) and a polymer chain (B). The polymer chain (A) contains 20-60% by mass of a constituent unit that is derived from a first cycloalkyl group-containing (meth)acrylate, 10-35% by mass of a constituent unit that is derived from a (meth)acrylic acid and 5-70% by mass of a constituent unit that is derived from another (meth)acrylate. The polymer chain (B) contains a constituent unit that is derived from a second cycloalkyl group-containing (meth)acrylate and/or a constituent unit that is derived from a (meth)acrylate or a vinyl monomer having an aromatic ring.
Patent AU-2013228006-B2 (AU)
Title: Albumin binding peptide-mediated disease targeting
Inventor: TRIEU VUONG
IPC: A61K39/00
Filed: 2013-09-11
Granted: 2016-05-12
Abstract: The invention provides compositions and methods for delivering a therapeutic or diagnostic agent to a disease site in a mammal, the method comprising administering to the mammal a therapeutically or diagnostically effective amount of a pharmaceutical composition, wherein the pharmaceutical composition comprises the therapeutic or diagnostic agent coupled to an albumin binding peptide and a pharmaceutically acceptable carrier.
Patent AU-2013251972-B2 (AU)
Title: Bearing monitoring method and system
Inventor: HAMILTON KEITH
IPC: F16C41/00
Filed: 2013-03-27
Granted: 2015-08-20
Abstract: A method for predicting the residual life of a rolling-element bearing (12) comprising the step of: measuring the magnitude and/or the frequency of occurrence of high frequency stress wave events emitted by rolling contact of said rolling-element bearing (12), recording said measurement data as recorded data, and predicting the residual life of said rolling-element bearing (12) using said recorded data and an International Organization for Standardization (ISO) rolling-element bearing life model. The accumulated fatigue damage is determined from the measurements of the magnitude and/or the number of high frequency stress wave events emitted by rolling contact of said bearing (12) rather than using said International Organization for Standardization (ISO) rolling-element bearing life model's values for the accumulated fatigue damage.
Patent AU-2013283563-B2 (AU)
Title: Pharmaceutical composition for treatment of the pulmonary form of altitude sickness caused by lack of oxygen and reduced air pressure
Inventor: FISCHER BERNHARD
IPC: A61P11/00
Filed: 2013-06-19
Granted: 2017-06-08
Abstract: What is described is a peptide which consists of 7‑20, especially 7‑17, adjacent amino acids and comprises the hexamer TX
Patent AU-2013288863-B2 (AU)
Title: Biologic sample collection devices and methods of production and use thereof
Inventor: MORHET JEFF
IPC: C08G63/08
Filed: 2013-07-08
Granted: 2015-04-02
Abstract: Collection devices and kits for biological sample collection include a biologic sample collection device having a hydrophilic swab matrix that includes a modified polycaprolactone (PCL). Methods of production and use thereof are also described herein. The biologic sample collection devices, kits and methods described herein are used to collect a biologic sample (e.g., blood, buccal cells, etc.) and to enable extraction of nucleic acids (e.g., DNA) from that biologic sample so that the nucleic acids can be analyzed (e.g., sequencing and subsequent analyses of DNA).
Patent AU-2013308128-B2 (AU)
Title: Antibacterial compositions
Inventor: BHAGWAT SACHIN
IPC: A61K31/43
Filed: 2013-05-13
Granted: 2017-11-02
Abstract: A pharmaceutical composition useful for the treatment or control of bacterial infections is disclosed.
Patent AU-2013311415-B2 (AU)
Title: Radiation detector for density or level measurements
Inventor: DALES KEVAN BRADLEY
IPC: G01T1/18
Filed: 2013-09-05
Granted: 2017-08-31
Abstract: A nucleonic density profiler includes a detector probe, for detecting ionising radiation, comprising an array of radiation detectors and a circuit board comprising at least two circuit board portions.
Patent AU-2013312430-B2 (AU)
Title: Process, method, and system for removing heavy metals from fluids
Inventor: O'REAR DENNIS JOHN
IPC: B01D47/00
Filed: 2013-09-06
Granted: 2018-04-05
Abstract: Trace levels of mercury in a natural gas are removed in a gas processing plant in an amine unit and / or a dehydrator. The mercury removal occurs concurrently with the removal of acid gases in an amine unit, e.g., an absorber or scrubber, with an amine solution containing a complexing agent. The mercury removal can also be carried out concurrently with the removal of water in a glycol dehydrator with the addition of a complexing agent to the glycol solution. Volatile mercury in the natural gas is removed by the complexing agent, forming non-volatile mercury species in the rich amine / glycol solution.
Patent AU-2013332374-B2 (AU)
Title: Defoaming agent compositions and methods of making and using same
Inventor: POBER KENNETH W
IPC: C09K8/38
Filed: 2013-09-18
Granted: 2015-12-03
Abstract: A method of servicing a wellbore in a subterranean formation comprising placing a foamed wellbore servicing fluid into a wellbore; flowing the foamed wellbore servicing fluid back to the wellbore surface; and contacting the foamed wellbore servicing fluid with an immobilized defoaming agent structure comprising an inert substrate and a defoamer. A system comprising a foamed wellbore servicing fluid in contact with a de-foaming structure, wherein the de-foaming structure comprises a defoamer covalently bonded to an inert substrate.
Patent AU-2013399065-B2 (AU)
Title: Optimized rotation of a drill string during a sliding mode of directional drilling
Inventor: DYKSTRA JASON D
IPC: E21B19/18
Filed: 2013-08-30
Granted: 2017-03-02
Abstract: An example method for optimized rotation of a drill string coupled to a drill bit and disposed within a borehole may comprise determining an angular velocity of at least part of the drill string. An angular velocity threshold to avoid static friction may also be determined. Additionally, a minimum input torque to apply to the drill string to maintain the angular velocity at or above the angular velocity threshold may be determined. The method may further include generating a control signal to a top drive motor based, at least in part, on the minimum input torque.
Patent AU-2014201947-B2 (AU)
Title: Capsule for preparing a beverage
Inventor: OLIVIER BRIVOIS
IPC: A47J31/06
Filed: 2014-04-04
Granted: 2016-05-12
Abstract: DESCRIPTIVE "Capsule for preparing a beverage" Capsule intended to receive a substance for preparing a beverage when the cap sule is installed in a machine of coffee machine type. The capsule has a bottom (1), and a side wall (3) forming overall part of a frustum of a cone and a flange (4) receiving a membrane seal (5) after loading of the capsule with the substance. The flat bottom (1) has a circular inner groove (12), centered on the axis (xx) of the capsule and corre sponding to the circle on which the pins of the piston of the extraction machine are lo cated. This groove (12) forms a local reduction of the bottom thickness leaving only a veil of material (123). The generally truncated cone-shaped side wall (3) has a cylindri cal wall (33) under the flange (4) and a base cylinder (31) close to the bottom (1), join ing the conical wall (33) by a conical junction (32) and the bottom (1) by a base truncated cone (2). -Figure 3 5272135_1 (GHMatters) P96752.AU 04/04/2014 4 45, Al -42 " + Fg3A --33(3 12 T 3 1(3 22) 7 2 - 24 xx 33 {35 W Fig 4 ixAN
Patent AU-2014211527-B2 (AU)
Title: Apparatus and method for generating a frequency enhanced signal using shaping of the enhancement signal
Inventor: DISCH SASCHA
IPC: G10L21/038
Filed: 2014-01-28
Granted: 2017-03-30
Abstract: An apparatus for generating a frequency enhancement signal (140) comprises: a calculator (500) for calculating a value describing an energy distribution with respect to frequency in a core signal (110, 120); and a signal generator (200) for generating an enhancement signal (130) comprising an enhancement frequency range not included in the core signal, from the core signal (502), wherein the signal generator (200) is configured for shaping the enhancement signal or the core signal so that a spectral envelope of the enhancement signal or of the core signal depends on the value (501) describing the energy distribution with respect to frequency in the core signal.
Patent AU-2014227557-B2 (AU)
Title: Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
Inventor: PIPKIN JAMES D
IPC: A61K31/715
Filed: 2014-09-22
Granted: 2016-02-25
Abstract: An inhalable formulation containing SAE-CD and corticosteroid is provided. The formulation is adapted for administration to a subject by nebulization with any known nebulizer. The formulation can be included in a kit. The formulation is administered as 5 an aqueous solution, however, it can be stored as a dry powder, ready-to-use solution, or concentrated composition. The formulation is employed in an improved nebulization system for administering corticosteroid by inhalation. SAE-CD present in the formulation significantly enhances the chemical stability of budesonide. A method of administering the formulation by inhalation is provided. The formulation can also be administered by 10 conventional nasal delivery apparatus.
Patent AU-2014227561-B2 (AU)
Title: ECM implant compositions and methods
Inventor: CHUTKA MICHELLE
IPC: A61L27/50
Filed: 2014-03-14
Granted: 2017-06-22
Abstract: Described our medical compositions and methods including a particulate extracellular matrix tissue in admixture with sugar. Such medical compositions, dried forms, can demonstrate enhanced rehydration properties. Medical compositions and products as described herein find particular use in treating diseased and/or damaged tissue, such as wound repair. Related methods of manufacture and use are also described.